WHO backs trials of two new Ebola vaccines
Written by AI from tv4.se's report. Not checked by a person.
The World Health Organization has approved clinical trials of two new Ebola vaccine candidates developed for the Bundibugyo virus. The outbreak is currently affecting Congo-Kinshasa.
The World Health Organization (WHO) approved clinical trials of two new Ebola vaccines on Wednesday, 4 November 2026. The decision comes while doctors are fighting an Ebola outbreak in Africa. The current outbreak, also called haemorrhagic fever, involves the Bundibugyo variant of the virus.
WHO chief Tedros Adhanom Ghebreyesus told journalists that the organisation's expert groups recommend adding two vaccine candidates to the clinical study that was drawn up in October against the Bundibugyo virus. He said the virus is currently ravaging Congo-Kinshasa.
According to the report, both candidates have been developed specifically for the Bundibugyo virus. One was developed by the University of Oxford together with the Serum Institute of India. The other was developed by Moderna.
The African Union's health agency, Africa CDC, says 5,300 people have died in the ongoing outbreak. Most of the deaths have been registered in Congo-Kinshasa.
